RET-Altered Cancers—A Tumor-Agnostic Review of Biology, Diagnosis and Targeted Therapy Activity
Article in Cancers (August 2023)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
An advanced pulmonary sarcomatoid carcinoma patient harboring a BRAFV600E mutation responds to dabrafenib and trametinib: a case report and literature review
Article in Frontiers in Oncology (July 2023)
A Metastatic Pulmonary Sarcomatoid Carcinoma Patient Harboring KIF5B-RET Fusion Responds to First-Line Pralsetinib Treatment: A Case Report
Article in Cancer Management and Research (July 2023)